Finance
For Verve Therapeutics Inc [VERV], Analyst sees a rise to $29. What next?
Verve Therapeutics Inc [NASDAQ: VERV] loss -34.95% or -4.47 points to close at $8.32 with a heavy trading volume of 10013678 shares. The company report on April 2, 2024 at 7:00 AM that Verve Therapeutics Announces Updates on its PCSK9 Program. Heart-1 clinical trial demonstrated
